South & Central America Helicobacter Pylori Non-invasive Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis

Description

List of Tables

The helicobacter pylori (H. pylori) non-invasive testing market in South & Central America is expected to grow from US$ 26.14 million in 2022 to US$ 34.64 million by 2028; it is estimated to grow at a CAGR of 4.8% from 2022 to 2028.

Introduction of Artificial Intelligence to Provide Opportunities to South & Central America Helicobacter

Pylori (H. pylori) Non-invasive Testing Market Players

The advancement in the field of computer technologies has led to the introduction of artificial intelligence technologies, which have been utilized to enhance the diagnosis and predict disease progression and treatment planning. Several studies have shown the capability of artificial intelligence in predicting H. pylori status for diagnosing gastritis. In 2019, Cancer Informatics and Inspirata entered into a technical partnership with DeePathology to grant joint customers the ability to utilize the DeePathology H. pylori decision support system, a screening tool, directly from Dynamyx, a digital pathology solution by Inspirata. The product can enhance reporting accuracy and safely accelerate the H. Pylori diagnostic process. Thus, the emergence of artificial intelligence will offer new opportunities for pharmaceutical companies, which is expected to provide growth opportunities to the helicobacter pylori (H. pylori) non-invasive testing market.

Market Overview

The number of cancer cases in Argentina is increasing at a steady rate. According to WHO, in 2020, ~130,878 new cases of cancer were diagnosed, of which 22,024 were breast cancer, while 15,605 were colorectal cancer and others. Further, ~70,000 deaths are caused by cancer per year, which is the third-highest cancer mortality rate in Latin America. Breast cancer is the most common type, with 73 cases per 100,000 women each year. Moreover, according to OECD, the healthcare expenditure in Argentina has increased. The surge is due to a growing need for health systems, infrastructure, human resources, diagnostics, treatment, and financing owing to the rising number of diseases and infections across the country. These factors are expected to provide significant growth opportunities to the (H. pylori) non-invasive testing market players during the forecast period.

South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market Segmentation

The South & Central America helicobacter pylori (H. pylori) non-invasive testing market is segmented on test type, test method, end user, and country.

Based on test type, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is segmented into serology, stool antigen, and urea breathe. In 2022, the urea breath segment is expected to hold the largest share of the market. Based on test method, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is bifurcated into laboratory based and point of care. The laboratory based segment is expected to hold a larger share of the market in 2022. Based on end user, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is segmented into hospitals, clinics, and diagnostic laboratories. The diagnostic laboratories segment is expected to hold the largest share of the market in 2022. Based on country, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is segmented into Brazil, Argentina, and the Rest of South & Central America. Further, Brazil is expected to hold the largest share of the market in 2022. Abbott Laboratories; Bio-Rad Laboratories Inc.; CerTest Biotec; Coris BioConcept; DiaSorin S.p.A.; Meridian Bioscience Inc.; QuidelOrtho Corporation; Sekisui Diagnostics; Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd; and Thermo Fisher Scientific Inc. are the leading companies operating in the helicobacter pylori (H. pylori) non-invasive testing market in South & Central America.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America helicobacter pylori (H. pylori) non-invasive testing market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America helicobacter pylori (H. pylori) non-invasive testing market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the helicobacter pylori (H. pylori) non-invasive testing market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Product Code: BMIRE00027546

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 SAM Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - By Test Type
- 1.3.2 SAM Helicobacter Pylori (H. pylori) Non-invasive Testing Market - By Test Method
- 1.3.3 SAM Helicobacter Pylori (H. pylori) Non-invasive Testing Market - By End User
- 1.3.4 SAM Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. SAM Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - Market Landscape

4.1 Overview
4.2 SAM PEST Analysis
4.3 Experts Opinion

5. SAM Helicobacter Pylori (H. pylori ) Non-Invasive Testing Market - Key Industry Dynamics

5.1 Key Market Drivers
- 5.1.1 Increasing prevalence of H. pylori bacterial infection
- 5.1.2 New Product Launches & FDA Approvals for Noninvasive Tests
- 5.1.3 Spreading Awareness Among Individuals Regarding Diagnosis of H. pylori
- 5.1.4 Rise in Investments by Pharmaceutical Companies
5.2 Key Market Restraints
- 5.2.1 Low Diagnosis Rate
5.3 Key Market Opportunities
- 5.3.1 Increasing Number of Conferences and Events for Research
- 5.3.2 Introduction of Artificial Intelligence
5.4 Future Trends
- 5.4.1 Increasing Use of Home-Based POC Devices
- 5.4.2 Diagnosis for Resistance
5.5 Impact Analysis

6. Helicobacter pylori (H. pylori ) Non-Invasive Testing Market- SAM Analysis

6.1 SAM Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue Forecast and Analysis

7. SAM Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Analysis- by Test Type

7.1 Overview
7.2 SAM Helicobacter pylori (H. pylori ) Non-invasive Testing Market, By Test Type 2022 & 2028 (%)
7.3 Serology Test
- 7.3.1 Overview
- 7.3.2 SAM Serology Test Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Stool Antigen Test
- 7.4.1 Overview
- 7.4.2 SAM Stool Antigen Test Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Urea Breath Test
- 7.5.1 Overview

8. SAM Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Analysis- by Test Method

8.1 Overview
8.2 SAM Helicobacter pylori (H. pylori) Non-invasive Testing Market, By Test Method 2022 & 2028 (%)
8.3 Laboratory Based Tests
- 8.3.1 Overview
- 8.3.2 SAM Laboratory Based Tests Market Revenue and Forecasts to 2028 (US$ Mn)
8.4 Point Of Care Tests
- 8.4.1 Overview
- 8.4.2 SAM Point of Care Tests Market Revenue and Forecasts to 2028 (US$ Mn)

9. SAM Helicobacter pylori (H. pylori ) Non-invasive Testing Market Analysis- by End User

9.1 Overview
9.2 SAM Helicobacter pylori (H. pylori ) Non-invasive Testing Market, By End User 2018 & 2028 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 SAM Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
9.4 Clinics
- 9.4.1 Overview
- 9.4.2 SAM Clinics Market Revenue and Forecasts to 2028 (US$ Mn)
9.5 Diagnostic Laboratories
- 9.5.1 Overview
- 9.5.2 SAM Diagnostic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)

10. SAM Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028 - Country Analysis

10.1 Overview
- 10.1.1 SAM Helicobacter pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028, By Country (%)
  - 10.1.1.1 Argentina Helicobacter pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
    - 10.1.1.1.1 Argentina Helicobacter pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
    - 10.1.1.1.2 Argentina Helicobacter pylori (H. pylori ) Non-invasive Testing Market Revenue And Forecasts to 2028, By Test (US$ Mn)
    - 10.1.1.1.3 Argentina Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue And Forecasts To 2028, By Test Method (US$ MN)
    - 10.1.1.1.4 Argentina Helicobacter pylori (H. pylori ) Noninvasive Testing Market Revenue And Forecasts to 2028, By End User (US$ Mn)
  - 10.1.1.2 Brazil Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
    - 10.1.1.2.1 Brazil Helicobacter pylori (H. pylori ) Noninvasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
    - 10.1.1.2.2 Brazil Helicobacter pylori (H. pylori ) Noninvasive Testing Market Revenue and Forecasts to 2028, By Test (US$ Mn)
    - 10.1.1.2.3 Brazil Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts To 2028, By Test Method (US$ MN)
    - 10.1.1.2.4 Brazil Helicobacter pylori (H. pylori ) Noninvasive Testing Market Revenue and Forecasts to 2028, By End User (US$ Mn)
  - 10.1.1.3 Rest of SAM Helicobacter pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
    - 10.1.1.3.1 Rest of SAM Helicobacter pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
    - 10.1.1.3.2 Rest of SAM Helicobacter pylori (H. pylori ) Non-invasive Testing Market Revenue And Forecasts to 2028, By Test (US$ Mn)
    - 10.1.1.3.3 Rest of SAM Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue And Forecasts To 2028, By Test Method (US$ MN)
    - 10.1.1.3.4 Rest of SAM Helicobacter pylori (H. pylori ) Non-invasive Testing Market Revenue And Forecasts to 2028, By End User (US$ Mn)

11. Helicobacter Pylori (H. Pylori ) Non-Invasive Testing Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Helicobacter Pylori (H. Pylori ) Non-Invasive Testing Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profile

12.1 DiaSorin S.p.A.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Meridian Bioscience, Inc.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 QuidelOrtho Corporation
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Abbott Laboratories
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 CerTest Biotec
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Sekisui Diagnostics
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Coris BioConcept
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Bio-Rad Laboratories, Inc.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms